World Heart Podcast

Play episode

Clara Chao

University of Sydney, Australia

David Plott

University of Michigan, USA

Carl Yu

Washington University School of Medicine, USA

Welcome to The Global Heart Podcast, the platform that connects evidence with real-world implementation for individuals living with cardiovascular disease across the world. Hosted by the World Heart Federation’s Senior Science Advisor and Global Heart Editor-in-Chief, this podcast brings together leading researchers and experts to discuss the latest findings and their impact on global heart health.

Download Episode

Follow our podcast

Apple Podcasts


Spotify


Deezer


Amazon Music


Podcast Index


Pocket Casts

Key Topics in This Episode

The World Heart Federation Roadmap on Secondary Prevention

Clara Chao introduces the updated World Heart Federation Roadmap on Secondary Prevention, an essential tool designed to enhance the implementation of evidence-based interventions for individuals with atherosclerotic cardiovascular disease. She highlights:

• The latest research and interventions since the roadmap’s initial release in 2015.
• The role of digital health and technology in supporting patient education, rehabilitation, and self-management.
• The increasing global acceptance and utilization of the polypill as a cost-effective solution for cardiovascular disease prevention.

Aspirin Use in Secondary Prevention: The Global Perspective

David Plott and Carl Yu delve into their research on aspirin use for secondary prevention in 51 low-, middle-, and high-income countries. Key insights include:

• Global disparities in aspirin use, with only 16.6% of eligible individuals in low-income countries adhering to treatment, compared to 65% in high-income nations.
• The impact of socioeconomic factors, healthcare infrastructure, and medication accessibility on treatment adherence.
• The need for health system strengthening to improve cardiovascular care in underserved regions.

Bridging the Gap: Implementation Science and Policy Solutions

Our experts discuss:

• Strategies to increase the uptake of evidence-based cardiovascular medications through policy reforms and education.
• The role of healthcare providers in addressing medication adherence challenges.
• The importance of gender equity in cardiovascular care, particularly in improving outcomes for women post-heart attack.

Key Takeaways:

• Secondary prevention is essential: Vascular disease remains the leading cause of death globally, making evidence-based interventions crucial.
• Equitable healthcare delivery matters: Addressing gender, socioeconomic, and regional disparities can significantly improve patient outcomes.
• Implementation research is key: Understanding how to adapt global guidelines to local settings can enhance patient access to life-saving treatments.
• Digital health as an enabler: Telemedicine and virtual care models can bridge gaps in healthcare access and improve adherence.
• Global collaboration is vital: A collective approach to cardiovascular research and policy development is essential for reducing the global burden of heart disease.